Pharming (PHAR) Assets Average (2021 - 2026)

Pharming (PHAR) has 6 years of Assets Average data on file, last reported at $478.7 million in Q2 2026.

• Quarterly Assets Average rose 12.7% year-over-year to $478.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $478.7 million (up 12.7% YoY) and the FY2025 annual result came in at $450.0 million, up 4.3% from the prior year.
• Assets Average eased to $478.7 million in Q2 2026, from $494.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $191.4 billion in Q4 2022 to a low of $196.6 million in Q1 2022.
• A 5-year average of $21.6 billion and a median of $431.0 million in 2023 frame the typical range for Assets Average.
• The widest YoY moves for Assets Average: up 95267.47% in 2022, down 99.91% in 2022.
• Tracing PHAR's Assets Average over 5 years: stood at $191.4 billion in 2022, then tumbled by 99.77% to $449.7 million in 2023, then fell by 8.21% to $412.7 million in 2024, then rose by 17.96% to $486.9 million in 2025, then slipped by 1.68% to $478.7 million in 2026.
• The last three Assets Average figures came in at $478.7 million (Q2 2026), $494.7 million (Q1 2026), and $486.9 million (Q4 2025), per Business Quant data.